PMID: 9422091Jan 9, 1998Paper

Affinity of antibodies to MUC1 antigens

Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
V KaranikasI F McKenzie

Abstract

The binding affinity of a monoclonal antibody to its ligand has been often used as a qualitative and quantitative measure for the specificity of the antibody. The aim of this paper was to assess the affinity of binding to recombinant and synthetic MUC1 peptides of 52 monoclonal antibodies as part of the ISOBM TD-4 Workshop. Affinity of binding was assessed using a surface plasmon resonance biosensor (BIAcore). The monoclonal antibodies exhibited variable affinity to MUC1 peptides, and overall 25/52 antibodies showed significant binding to the test peptides with affinities ranging from 2.4 x 10(6) to 3.1 x 10(8) M-1. Affinities calculated by analysis of kinetic biosensor data agreed well with affinities determined by equilibrium binding analysis of radiolabelled antibodies. The affinity measurements may provide help when determining the use of various monoclonals in tumour biology research.

Citations

Sep 5, 2003·Hybridoma and Hybridomics·M PaknejadM Rajabi Bazl
Jan 26, 2011·PloS One·Holger ThieStefan Dübel
Dec 28, 1999·Journal of Molecular Recognition : JMR·D G Myszka
Dec 18, 2007·Journal of Cellular and Molecular Medicine·R F SmithA A Smith
Nov 3, 2005·British Journal of Cancer·L M PericleousM P Deonarain
Jan 7, 2005·Biopolymers·Jason T SchumanA Patricia Campbell

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biosensors for Cancer Detection

Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents.

Related Papers

Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
M R PriceJ Hilgers
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
A BlockzjilO Nilsson
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
P D Rye, M A McGuckin
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
Richard G SmithMichael R Price
© 2021 Meta ULC. All rights reserved